Indianapolis, Indiana-headquartered Eli Lilly inaugurated a new technology and innovation center in Hyderabad, India, marking an expansion of its global digital capabilities. The site will serve as a hub focused on artificial intelligence, automation, cloud computing, and software engineering. The Hyderabad center has already hired 100 professionals and plans to...
Eli Lilly Launches Drug for Psoriasis in India
Indianapolis, Indiana-headquartered Eli Lilly launched Copellor (Ixekizumab) in India to treat adults that have moderate-to-severe plaque psoriasis and who are candidates for systemic therapy or phototherapy. The drug will also be available for the treatment of adult patients with active psoriatic arthritis. Psoriasis is a chronic auto-immune disorder of the...
Eli Lilly Expands its India Market with Trulicity
In a move to enhance its diabetes portfolio in India, Indianapolis, Indiana-based Eli Lilly launched a once-a-week diabetes treatment drug under the brand name Trulicity, a glucagon-like peptide-1 (GLP-1) receptor agonist, a hormone that helps normalize blood sugar levels in those with Type 2 diabetes, reports BusinessLine. Priced at $37.15,...